Can a personalized screening plan catch breast cancer just as well?
NCT ID NCT03672331
Summary
This large international study is testing whether a personalized breast cancer screening plan, based on a woman's individual risk, works as well as the standard one-size-fits-all schedule. Over 53,000 women aged 40-70 will be randomly assigned to follow either their country's standard screening guidelines or a new, risk-based plan for four years. The main goal is to see if the personalized approach catches serious breast cancers (stage 2 or higher) at least as effectively as the standard method.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST SCREENING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AUSL Reggio Emilia
Reggio Emilia, Emilia-Romagna, Italy
-
Assuta Medical Center Ramat HaHayal
Tel Aviv, Israel
-
Cambridge University Hospitals NHS Foundation Trust
Cambridge, Cambridgeshire, United Kingdom
-
Gustave roussy
Villejuif, France
-
Institut Jules Bordet
Brussels, Belgium
-
Marta Romản
Barcelona, Spain
Conditions
Explore the condition pages connected to this study.